Search for: "Commitment of M B" Results 1921 - 1940 of 3,692
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jun 2011, 9:25 am by Jack Goldsmith
  I’m sure we’ll be hearing more about internal Administration legal disputes over the WPR. [read post]
4 Jun 2010, 12:44 pm by Ariel Katz
Benjamin Netanyahu, I'm sure that you are truly convinced that you are fighting for the noblest of causes. [read post]
2 Jun 2010, 8:15 am by David Bernstein
I’m not an international law expert, and it’s not my cup of tea, but if you’re going to cite international law, you might as well get it right, and my understanding is that Greenwald is simply wrong here. [read post]
30 Jul 2009, 8:39 pm
Ahuja, the appellant, had filed two criminal complaints, under Section 138 of the NI Act, against M/S Motorol Speciality Oils Ltd. [read post]
11 Jul 2023, 8:06 am by Max Kohn
”  “Federal health care programs are an important resource for millions of Americans to receive medical care,” said Special Agent in Charge Timothy B. [read post]
21 Jul 2023, 6:59 am by Gene Takagi
In With Plan B Equity and Justice: Forcing people to work in deadly heat is mostly legal in the U.S. [read post]
23 Jul 2008, 11:12 am
I'm fine with that, but some of you may recoil in horror at the thought. [read post]
22 May 2019, 5:34 am by Stephen M. Ozcomert
If you were injured by a dangerous condition on somebody else’s property, premises liability attorney Stephen M. [read post]
31 Jan 2011, 2:34 pm by Adam Goodman
The offence is defined in s. 430 (1) of the Criminal Code: 430. (1)  Everyone one commits mischief who wilfully, (a) destroys or damages property; (b) renders property dangerous, useless, inoperative or ineffective; (c) obstructs, interrupts or interferes with the lawful use, enjoyment or operation of property; or (d) obstructs, interrupts or interfereres with any person in the lawful use, enjoyment or operation of property. [read post]
2 Jan 2012, 6:25 pm by FDABlog HPM
  If a product meets these criteria, then FDA may grant marketing approval based on a demonstrated effect on a surrogate endpoint reasonably likely to predict clinical benefit and a sponsor’s commitment to complete with due diligence the required postmarketing studies to confirm the product’s clinical benefits. [read post]
9 Jan 2008, 4:01 pm
" That being said, I also believe that Lyndon B. [read post]